FRENCH J MICHAELdirector, officer: President and CEOdirector, officer: President an..
MDRNA, Inc. Common Stock
100
$0.76
$76
Sale
COSTANTINO HENRY Rofficer: CSO - Deliveryofficer: CSO - Delivery
MDRNA, Inc. Common Stock
231
$1.01
$233
Sale
COSTANTINO HENRY Rofficer: CSO - Deliveryofficer: CSO - Delivery
MDRNA, Inc. Common Stock
240
$1.17
$281
Sale
COSTANTINO HENRY Rofficer: CSO - Deliveryofficer: CSO - Delivery
MDRNA, Inc. Common Stock
81
$1.19
$96
Sale
DUFFY TIMOTHY Mofficer: Chief Business Officerofficer: Chief Business Officer
MDRNA, Inc. Common Stock
200
$1.19
$238
Purchase
THAW BRUCE R/FAdirectordirector
Nastech Pharmaceutical Company Common Stock
4,112
$1.33
$5,469
Purchase
THAW BRUCE R/FAdirectordirector
Nastech Pharmaceutical Company Common Stock
2,500
$1.23
$3,075
Purchase
THAW BRUCE R/FAdirectordirector
Nastech Pharmaceutical Company Common Stock
4,086
$1.13
$4,617
Purchase
THAW BRUCE R/FAdirectordirector
Nastech Pharmaceutical Company Common Stock
800
$1.14
$912
Purchase
THAW BRUCE R/FAdirectordirector
Nastech Pharmaceutical Company Common Stock
36,602
$1.15
$42,092
Purchase
THAW BRUCE R/FAdirectordirector
Nastech Pharmaceutical Company Common Stock
1,900
$1.24
$2,356
Purchase
STANEWICK GERALD Tdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
10,000
$1.14
$11,400
Purchase
STANEWICK GERALD Tdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
4,100
$2.4
$9,840
Purchase
STANEWICK GERALD Tdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
900
$2.39
$2,151
Purchase
YORK BRUCE Rofficer: CFO and Secretaryofficer: CFO and Secretary
Nastech Pharmaceutical Company Inc Common Stock
2,000
$4.04
$8,080
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
100
$14.41
$1,441
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
1,000
$14.85
$14,850
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
1,000
$14.85
$14,850
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
167
$14.73
$2,460
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
200
$14.71
$2,942
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
133
$14.7
$1,955
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
400
$14.42
$5,768
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
1,000
$16
$16,000
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
500
$16.05
$8,025
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
100
$14
$1,400
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
100
$14
$1,400
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
100
$14
$1,400
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
200
$13.8
$2,760
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
100
$14
$1,400
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
100
$14
$1,400
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
200
$13.8
$2,760
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
300
$13.48
$4,044
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
100
$14
$1,400
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
200
$13.8
$2,760
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
200
$13.8
$2,760
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
200
$13.8
$2,760
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
200
$13.8
$2,760
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
200
$13.8
$2,760
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
100
$14
$1,400
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
200
$13.8
$2,760
Sale
WENIG DEVINdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
400
$13.75
$5,500
Sale
QUAY STEVEN Cdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
1,000
$13.53
$13,530
Sale
QUAY STEVEN Cdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
2,000
$13.52
$27,040
Sale
QUAY STEVEN Cdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
2,000
$13.52
$27,040
Sale
QUAY STEVEN Cdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
200
$13.42
$2,684
Sale
STANEWICK GERALD Tdirectordirector
Nastech Pharmaceutical Company Inc Common Stock
4,200
$14.21
$59,695
Option
JOHNSON PAUL Hofficer: Sr VP of R&D, CSOofficer: Sr VP of R&D, CSO
Nastech Pharmaceutical Company Inc Common Stock
54,649
$9.36
$511,515
Sale
JOHNSON PAUL Hofficer: Sr VP of R&D, CSOofficer: Sr VP of R&D, CSO
Nastech Pharmaceutical Company Inc Common Stock
2,200
$14.3
$31,460
Option
JOHNSON PAUL Hofficer: Sr VP of R&D, CSOofficer: Sr VP of R&D, CSO
Nastech Pharmaceutical Company Inc Common Stock
2,667
$10.39
$27,710
Sale
JOHNSON PAUL Hofficer: Sr VP of R&D, CSOofficer: Sr VP of R&D, CSO
Nastech Pharmaceutical Company Inc Common Stock
45,000
$14.3
$643,500
Showing 100 to 150 of 301 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.